| Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
|---|
| 08/09/2006 | EP1687404A2 Methods and compositions related to a matrix chip |
| 08/09/2006 | EP1687403A2 Methods and compositions for detection of segmented negative strand rna viruses |
| 08/09/2006 | EP1687402A2 Chimeric metabotropic glutamate receptors and uses thereof |
| 08/09/2006 | EP1687401A2 Site-specific incorporation of redox active amino acids into proteins |
| 08/09/2006 | EP1687400A2 Cell culture methods and devices utilizing gas permeable materials |
| 08/09/2006 | EP1687398A2 Hiv-dependent expression constructs and uses therefor |
| 08/09/2006 | EP1687397A2 Improved apparatus and method for identification of biomolecules, in particular nucleic acid sequences, proteins, and antigens and antibodies |
| 08/09/2006 | EP1687325A2 Novel sequences encoding hapatitis c virus glycoproteins |
| 08/09/2006 | EP1687323A2 Methods and compositions for seamless cloning of nucleic acid molecules |
| 08/09/2006 | EP1687022A2 Renta: an hiv immunogen and uses thereof |
| 08/09/2006 | EP1687017A2 Methods and compositions for delivering polynucleotides |
| 08/09/2006 | EP1687016A2 Diphtheria toxin variant |
| 08/09/2006 | EP1644534A4 Genome mapping of functional dna elements and cellular proteins |
| 08/09/2006 | EP1620538A4 Trasngenic expression of a phytochrome a gene |
| 08/09/2006 | EP1539790A4 Method of haplotype-based genetic analysis for determining risk for developing insulin resistance, coronary artery disease and other phenotypes |
| 08/09/2006 | CN1816636A Genome mapping of functional DNA elements and cellular proteins |
| 08/09/2006 | CN1816632A Acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous yeasts |
| 08/09/2006 | CN1816630A Delta-12 desaturase gene suitable for altering levels of polyunsaturated fatty acids in oleaginous yeasts |
| 08/09/2006 | CN1816559A Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts |
| 08/08/2006 | US7087403 Polypeptides which codes mutant phytoene desaturase gene; genetic engineered cells |
| 08/03/2006 | WO2005059098A3 Methods and compositions for treating and/or preventing neurodegenerative conditions |
| 08/03/2006 | WO2005056756A3 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 08/03/2006 | WO2005001044A3 Compositions related to pleiotrophin methods and uses thereof |
| 08/03/2006 | WO2004096980A3 Novel polynucleotides encoding soluble polypeptides and methods using same |
| 08/03/2006 | US20060172959 Selected rna motifs to include cell death and/or apoptosis |
| 08/03/2006 | US20060172415 Oligodendrocyte precursor cells and method of obtaining and culturing the same |
| 08/03/2006 | US20060172408 Device for immobilizing chemical and biochemical species and methods of using same |
| 08/03/2006 | US20060172305 Method for determining susceptibility of tumor to treatment with anti-neoplastic agent |
| 08/03/2006 | US20060172304 Method for modulating epithelial stem cell lineage |
| 08/03/2006 | US20060172292 Multivariate random search method with multiple starts and early stop for identification of differentially expressed genes based on microarray data |
| 08/03/2006 | US20060172011 Medical treatment |
| 08/03/2006 | US20060171955 Process for increasing rsv surface glycoprotein yields using a mutant strain of rsv |
| 08/03/2006 | US20060171924 Bidirectional promoters for small RNA expression |
| 08/02/2006 | EP1685245A2 A process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby |
| 08/02/2006 | EP1685240A2 Improved methods of in vitro protein synthesis |
| 08/02/2006 | EP1685239A2 Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oilseed plants and oleaginous yeast |
| 08/02/2006 | EP1685238A2 Hcv replicons containing ns5b from genotype 2b |
| 08/02/2006 | EP1685236A2 Methods for altering hematopoietic progenitor cell adhesion, differentiation, and migration |
| 08/02/2006 | EP1685235A2 Cell culture tool and method |
| 08/02/2006 | EP1685148A2 PORCINE ISOGLOBOSIDE 3 SYNTHASE PROTEIN, cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION |
| 08/02/2006 | EP1684800A2 In vivo efficacy of ny-eso-1 plus adjuvant |
| 08/02/2006 | EP1684782A2 Process for the synchronization of ovulation for timed breeding without heat detection |
| 08/02/2006 | EP1684764A2 Methods for treating diseases and conditions with inverse agonists and for screening for agents acting as inverse agonists |
| 08/02/2006 | EP1684745A2 Hepatitis c virus inhibitors |
| 08/02/2006 | EP1476561A4 Amplifying repetitive nucleic acid sequences |
| 08/02/2006 | EP0914339B1 RET LIGAND 3 (RetL3) FOR STIMULATING NEURAL AND RENAL GROWTH |
| 08/02/2006 | CN1813187A Nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 08/02/2006 | CN1813067A Trasngenic expression of a phytochrome a gene |
| 08/02/2006 | CN1813059A Solid phase cell lysis and capture platform |
| 08/02/2006 | CN1812824A 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 08/02/2006 | CN1812803A Human mast cell-expressed membrane protein |
| 08/02/2006 | CN1812779A Compounds for treatment of inflammation, diabetes and related disorders |
| 08/02/2006 | CN1267452C Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
| 08/02/2006 | CN1267447C Method for segregating nucleic acid |
| 08/02/2006 | CN1267446C Nucleoside derivatives as inhibitors of RNA-dependent PNA viral polymerase |
| 08/01/2006 | US7083931 Polypeptides; green fluorescent protein ; genetic engineering |
| 08/01/2006 | US7083788 Modulators of the function of receptors of the TNF/NGF receptor family and other proteins |
| 07/27/2006 | WO2005029041A3 High density sequence detection methods and apparatus |
| 07/27/2006 | WO2004094614A3 Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics |
| 07/27/2006 | WO2004074456A3 Methods for selecting medications |
| 07/27/2006 | US20060166977 Antibacterial agents |
| 07/27/2006 | US20060166263 Randomized libraries of zinc finger proteins |
| 07/27/2006 | US20060166258 Preservation of RNA in a biological sample |
| 07/27/2006 | US20060166245 Rolling circle amplification of micro-RNA samples |
| 07/27/2006 | US20060166215 Assay and process for labeling and detection of micro rna and small interfering rna sequences |
| 07/27/2006 | US20060166214 Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker |
| 07/26/2006 | EP1682677A2 Differential enzymatic fragmentation |
| 07/26/2006 | EP1682664A2 Methods for the production of apolipoproteins in transgenic plants |
| 07/26/2006 | EP1682567A2 Delta12 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous yeast |
| 07/26/2006 | EP1682566A2 Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous plants and yeast |
| 07/26/2006 | EP1682179A2 Enhanced b cell cytotoxicity of cdim binding antibody |
| 07/26/2006 | EP1681921A2 Method for two- and three-dimensional microassembly of patterns and structures |
| 07/26/2006 | EP1590482A4 Nucleic acid amplification using non-standard bases |
| 07/26/2006 | EP0967991B1 Infectious bursitis vaccine |
| 07/26/2006 | CN1809644A Fine mapping of chromosome 17 quantitative trait loci and use of same for marker assisted selection |
| 07/20/2006 | WO2004111197A3 Gene expression signatures, methods and compositions for diagnosing disorders of the lung |
| 07/20/2006 | WO2004099367A3 Methods for producing zinc finger proteins that bind to extended dna target sequences |
| 07/20/2006 | WO2004099366A3 Context sensitive parallel optimization of zinc finger dna binding domains |
| 07/20/2006 | US20060162018 Plant transcriptional regulators of disease resistance |
| 07/20/2006 | US20060162014 Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules |
| 07/20/2006 | US20060160826 Methods of treating ischemic related conditions |
| 07/20/2006 | US20060160217 Novel nucleic acids from sesame plants |
| 07/20/2006 | US20060160213 Enhancement of mammalian embryo development |
| 07/20/2006 | US20060160201 Three-dimensional structures of HDAC9 and Cabin1 and compound structures and methods related thereto |
| 07/20/2006 | US20060160193 Suitable for use in the manufacture of microbial oils enriched in omega fatty acids in oleaginous yeast (e.g., Yarrowia lipolytica) |
| 07/20/2006 | US20060160090 Composition splice variants and methods relating to cancer specific genes and proteins |
| 07/20/2006 | US20060159708 Vascular Leak Syndrome; polypeptide toxophore from a DT; has cytotoxicity comparable to that of a DT molecule |
| 07/19/2006 | EP1680500A2 High temperature and alkaline stable catalase |
| 07/19/2006 | EP1680437A2 Motoneuronotrophic factor gene sequences |
| 07/19/2006 | CN1805928A Prodrugs of mitotic kinesin inhibitors |
| 07/19/2006 | CN1805740A Compositions for down-regulation of CCR5 expression and methods of use thereof |
| 07/18/2006 | US7078416 Polypeptides |
| 07/18/2006 | US7078196 Genetic engineering ; induction post-transcriptional gene blocking |
| 07/13/2006 | WO2005042699A3 Modified polypeptides with therapeutic activity and methods of use |
| 07/13/2006 | WO2005033286A3 Compositions and methods for synthesizing, purifying and detecting biomolecules |
| 07/13/2006 | WO2005033280A3 Hiv-dependent expression constructs and uses therefor |
| 07/13/2006 | WO2004090100A3 Visualizing expression data on chromosomal graphic schemes |
| 07/13/2006 | US20060156419 Mouse model for autoimmune disorders |
| 07/13/2006 | US20060155115 Multivalent T cell receptor complexes |
| 07/13/2006 | US20060154857 G1 phase arresting compound is rapamycin and the HIV antiviral agent is T20 (enfuvirtide); enhances the activity of the antiviral agent |